Institutional Ownership Neurocrine Biosciences Inc (NBIX)
This table provides information about the institutional ownership of Neurocrine Biosciences Inc (NBIX). We have compiled data on the 651 institutions that hold shares in the stock, with a total of 97.3 Million shares, which have been reported (via 13F filing form) to have a value of $13 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Clearbridge Investments, LLC
New York, NY |
May 13, 2025 Q1 2025 |
342,302
shares
|
$45.7 Million
0.03% of portfolio
|
Q1 2025
Added 7.2%
|
|
Hood River Capital Management LLC
Palm Beach Gardens, FL |
May 15, 2025 Q1 2025 |
337,164
shares
|
$45 Million
0.71% of portfolio
|
Q1 2025
Reduced 5.04%
|
|
Axa S.A.
Paris, I0 |
May 15, 2025 Q1 2025 |
333,699
shares
|
$44.6 Million
0.13% of portfolio
|
Q1 2025
Added 12.09%
|
|
Candriam S.C.A.
|
May 14, 2025 Q1 2025 |
330,840
shares
|
$44.2 Million
0.24% of portfolio
|
Q1 2025
Added 8.84%
|
|
Ameriprise Financial Inc
Minneapolis, MN |
May 14, 2025 Q1 2025 |
315,710
shares
|
$42.2 Million
0.01% of portfolio
|
Q1 2025
Reduced 23.65%
|
|
Rhumbline Advisers
Boston, MA |
May 29, 2025 Q1 2025 |
314,486
shares
|
$42 Million
0.03% of portfolio
|
Q4 2024
Added 1.91%
|
|
Sarissa Capital Management LP
Greenwich, CT |
May 15, 2025 Q1 2025 |
309,116
shares
|
$41.3 Million
9.33% of portfolio
|
Q4 2024
Reduced 24.69%
|
|
Nuveen, LLC
Charlotte, NC |
May 12, 2025 Q1 2025 |
286,496
shares
|
$38.3 Million
0.01% of portfolio
|
Q1 2025
New holding
|
|
Swiss National Bank
Zurich, V8 |
May 12, 2025 Q1 2025 |
285,500
shares
|
$38.1 Million
0.02% of portfolio
|
Q1 2025
Added 0.07%
|
|
Rock Springs Capital Management LP
Baltimore, MD |
May 15, 2025 Q1 2025 |
279,000
shares
|
$37.2 Million
1.84% of portfolio
|
Q1 2025
Reduced 61.28%
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
267,980
shares
|
$35.8 Million
0.01% of portfolio
|
Q4 2024
Reduced 22.45%
|
|
Wells Fargo & Company
San Francisco, CA |
May 13, 2025 Q1 2025 |
255,391
shares
|
$34.1 Million
0.01% of portfolio
|
Q1 2025
Added 3.57%
|
|
Principal Financial Group Inc
Des Moines, IA |
Apr 28, 2025 Q1 2025 |
248,420
shares
|
$33.2 Million
0.02% of portfolio
|
Q1 2025
Reduced 1.6%
|
|
Hsbc Holdings PLC
London, X0 |
May 14, 2025 Q1 2025 |
243,035
shares
|
$32.4 Million
0.02% of portfolio
|
Q1 2025
Added 14.45%
|
|
George Soros
Soros Fund Management LLC | New York, Ny
|
May 15, 2025 Q1 2025 |
239,823
shares
|
$32 Million
0.64% of portfolio
|
Q1 2025
Added 19.91%
|
|
Sumitomo Mitsui Trust Holdings, Inc.
|
Apr 25, 2025 Q1 2025 |
231,458
shares
|
$30.9 Million
0.02% of portfolio
|
Q1 2025
Reduced 0.6%
|
|
Macquarie Group LTD
Australia, C3 |
May 15, 2025 Q1 2025 |
231,348
shares
|
$30.9 Million
0.03% of portfolio
|
Q1 2025
Reduced 15.61%
|
|
Amundi
Paris, I0 |
May 15, 2025 Q1 2025 |
231,187
shares
|
$30.9 Million
0.01% of portfolio
|
Q1 2025
Reduced 11.71%
|
|
Eagle Health Investments LP
Greenwich, CT |
May 12, 2025 Q1 2025 |
225,100
shares
|
$30.1 Million
6.46% of portfolio
|
Q1 2025
Added 45.23%
|
|
Abrdn PLC
|
May 13, 2025 Q1 2025 |
220,344
shares
|
$29.4 Million
0.05% of portfolio
|
Q1 2025
Added 40.73%
|
|
Gamma Investing LLC
Foster City, CA |
Apr 07, 2025 Q1 2025 |
219,099
shares
|
$29.3 Million
0.01% of portfolio
|
Q1 2025
Reduced 99.1%
|
|
Renaissance Group LLC
Covington, KY |
May 13, 2025 Q1 2025 |
212,100
shares
|
$28.3 Million
1.07% of portfolio
|
Q1 2025
Reduced 2.52%
|
|
Alyeska Investment Group, L.P.
Chicago, IL |
May 15, 2025 Q1 2025 |
206,368
shares
|
$27.6 Million
0.1% of portfolio
|
Q1 2025
Reduced 17.1%
|
|
Scout Investments, Inc.
|
Nov 12, 2024 Q3 2024 |
203,501
shares
|
$27.2 Million
0.69% of portfolio
|
Q3 2024
Added 7.18%
|
|
Barclays PLC
London, X0 |
May 15, 2025 Q1 2025 |
200,218
shares
|
$26.7 Million
0.01% of portfolio
|
Q1 2025
Added 12.25%
|